StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Stock Performance
Shares of NAVB stock opened at $0.04 on Friday. Navidea Biopharmaceuticals has a one year low of $0.02 and a one year high of $0.28. The company has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.05. The firm has a market capitalization of $3.68 million, a price-to-earnings ratio of -0.62 and a beta of 1.13.
Navidea Biopharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Navidea Biopharmaceuticals
- Buy P&G Now, Before It Sets A New All-Time High
- High-Yield Texas Instruments Could Hit New Highs Soon
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.